Funder: National Institutes of Health
Due Dates: September 25, 2025 (anticipated NOFO release)
Funding Amounts: Estimated $3,300,000 total; single-source cooperative agreement; typical duration not specified.
Summary: Supports the continued distribution of human islets to researchers for diabetes studies via the Integrated Islet Distribution Program.
Key Information: This is a notice of intent; applications are not yet being solicited.
Description
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at NIH intends to issue a Notice of Funding Opportunity (NOFO) for a single-source cooperative agreement to continue the Integrated Islet Distribution Program (IIDP) at the Beckman Research Institute/City of Hope. The IIDP is a critical resource for the diabetes research community, providing human islets for biomedical research to advance understanding of islet cell biology and support the development of new therapies for diabetes prevention and treatment.
The program manages partnerships with islet isolation facilities, oversees the distribution of human islets, manages investigator eligibility and cost recovery, and ensures standardized phenotypic and genotypic analyses of distributed islet preparations. This notice is intended to give potential applicants time to develop collaborations and responsive projects in anticipation of the forthcoming NOFO.
Due Dates
- Anticipated NOFO Release: September 25, 2025
- Applications are not being solicited at this time. This is a notice of intent only.
Funding Amount
- Estimated Total Funding: $3,300,000 (single-source award)
- Funding Mechanism: Cooperative Agreement (U24 Resource-Related Research Projects)
- Award Duration: Not specified in the notice
Eligibility
- This will be a single-source award to the Beckman Research Institute/City of Hope for the continuation of the IIDP.
- The notice encourages investigators with expertise in live cell distribution, human islet biology, and coordinating center administration to consider collaborative projects for the upcoming NOFO.
- Typical NIH eligibility for U24 awards includes:
- Public and private institutions of higher education
- Nonprofits (with or without 501(c)(3) status)
- For-profit organizations (including small businesses)
- State, local, and tribal governments
- Other eligible organizations as defined by NIH
Application Process
- No applications are being accepted at this time.
- This is a notice of intent to publish a future NOFO.
- Interested researchers are encouraged to begin developing collaborations and project ideas in anticipation of the official funding announcement.
Additional Information
- The IIDP is a key resource for distributing human islets to the diabetes research community.
- The program includes management of islet isolation partnerships, investigator eligibility, cost recovery, and standardized analyses.
- Collaborative projects combining expertise in islet biology and program administration are encouraged.
External Links
Contact Information
| Contact Type | Details |
|---|
| NIH Main Line | 301-496-4000 |
| NIH Contact Page | Contact NIH |